BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cambridge Population Health Sciences - ECPv6.15.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cambridge Population Health Sciences
X-ORIGINAL-URL:https://www.phs.group.cam.ac.uk
X-WR-CALDESC:Events for Cambridge Population Health Sciences
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260227T130000
DTEND;TZID=Europe/London:20260227T140000
DTSTAMP:20260514T093651
CREATED:20260203T174142Z
LAST-MODIFIED:20260408T103509Z
UID:2107-1772197200-1772200800@www.phs.group.cam.ac.uk
SUMMARY:Bradford Hill Seminar - Leveraging External Data for Testing Experimental Therapies with Biomarker Interactions in Randomized Clinical Trials
DESCRIPTION:All are invited to the hybrid Bradford Hill Seminar: \nLeveraging External Data for Testing Experimental Therapies with Biomarker Interactions in Randomized Clinical Trials\nProfessor Lorenzo Trippa\nHarvard T.H. Chan School of Public Health and Dana-Farber Cancer Institute \nRegister to attend\nPlease note this will be a hybrid event. \nAttend in person at: Large Downstairs Teaching Room\, East Forvie Building\, Forvie Site\, Robinson Way\, Cambridge CB2 0SR. \nRegister to attend online at: cam-ac-uk.zoom.us/meeting/register/f9LMsIBDQwqxwpWM0Fr9Hw#/registration \n  \nAbstract\nIn oncology the efficacy of novel therapeutics often differs across patient subgroups\, and these variations are difficult to predict during the initial phases of the drug development process. The relation between the power of randomized clinical trials and heterogeneous treatment effects has been discussed by several authors. In particular\, false negative results are likely to occur when the treatment effects concentrate in a subpopulation but the study design did not account for potential heterogeneous treatment effects. The use of external data from completed clinical studies and electronic health records has the potential to improve decision-making throughout the development of new therapeutics\, from early-stage trials to registration. \nHere we discuss the use of external data to evaluate experimental treatments with potential heterogeneous treatment effects. We introduce a permutation procedure to test\, at the completion of a randomized clinical trial\, the null hypothesis that the experimental therapy does not improve the primary outcomes in any subpopulation. The permutation test leverages the available external data to increase power. Also\, the procedure controls the false positive rate at the desired 𝛼-level without restrictive assumptions on the external data\, for example\, in scenarios with unmeasured confounders\, different pre-treatment patient profiles in the trial population compared to the external data\, and other discrepancies between the trial and the external data. We illustrate that the permutation test is optimal according to an interpretable criteria and discuss examples based on asymptotic results and simulations\, followed by a retrospective analysis of individual patient-level data from a collection of glioblastoma clinical trials. \nAbout Professor Trippa\nLorenzo Trippa\, PhD\, is a professor of biostatistics at Harvard T.H. Chan School of Public Health and Dana-Farber Cancer Institute. His research focuses on statistical methods for clinical trial design\, with an emphasis on Bayesian and adaptive approaches\, external controls\, and precision oncology. Trippa’s work aims to improve the efficiency and reliability of trials in complex settings\, particularly in cancer research\, and has connects methodological research and applied clinical studies. \nAbout the Bradford Hill seminars\nThe Bradford Hill seminar series is the principal series of The Cambridge Population Health Sciences Partnership\, in collaboration with the PHG Foundation. This comprises the Departments of Public Health & Primary Care\, MRC Biostatistics Unit and MRC Epidemiology Unit at the University of Cambridge\, bringing together a multi-disciplinary partnership of academics and public health professionals. The Bradford Hill seminar programme of internationally recognised speakers covers topics of broad interest to our public health research community. It aims to transcend as well as connect the activities of our individual partners. \nAll are welcome at our Bradford Hill seminars.
URL:https://www.phs.group.cam.ac.uk/event/bradford-hill-seminar-leveraging-external-data-for-testing-experimental-therapies/
LOCATION:Large Downstairs Teaching Room\, East Forvie Building\, Forvie Site\, Robinson Way\, Cambridge CB2 0SR\, East Forvie Building\, Cambridge\, Cambridgeshire\, CB2 0SR\, United Kingdom
END:VEVENT
END:VCALENDAR